Abstract Background: The MelanomAIX project developed an AI-based framework to identify image-derived digital biomarkers predictive of immunotherapy response in malignant melanoma. Histopathological slides contain rich subvisual information that reflects tumor-immune interactions often missed by conventional assessment. By combining deep learning-based tissue characterization with molecular and clinical data, MelanomAIX leverages routine pathology for biomarker discovery and precision oncology. Methods: A real-world cohort of 200 melanoma patients was assembled from multiple clinical archives. Each case was curated with digitized H Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1454.
Building similarity graph...
Analyzing shared references across papers
Loading...
Theresa Koehler
Eleftherios Mylonakis
Raluca Wroblewski
Cancer Research
Asklepios Kliniken Hamburg
Institut für Hämatopathologie Hamburg
Hamburg Port Consulting (Germany)
Building similarity graph...
Analyzing shared references across papers
Loading...
Koehler et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d1fceba79560c99a0a2aa3 — DOI: https://doi.org/10.1158/1538-7445.am2026-1454
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: